Newsroom Login

VERITY

Truth. Clarity. Insight.

Fusion Research Facility Achieves Net Energy Gain Milestone in Fusion Physics

By Sarah Jenkins
Sunday, June 21, 2026 at 07:47 PM
1 min read
Fusion Research Facility Achieves Net Energy Gain Milestone in Fusion Physics
In Short (TL;DR)

Using advanced magnetic confinement, the reactor sustained a high-temperature plasma, generating more energy than consumed.... This represents the direct, synthesized summary of the ongoing situation.

TOKYO — The National Institute for Fusion Science today announced that its experimental fusion reactor sustained a high-temperature deuterium plasma for a record 120 seconds, achieving a net energy gain of 1.25.

The milestone represents a major step forward for commercial fusion power development.

Fusion Energy Achievements * **Plasma Temperature**: Reached over 120 million degrees Celsius, hotter than the core of the sun. * **Magnetic Confinement**: Utilized next-gen superconducting magnets to stabilize the plasma. * **Energy Gain (Q)**: Generated 25% more thermal energy than the electrical input required to heat the plasma.

NIFS directors stated, 'Sustaining high-temperature plasma for two minutes is a major milestone for fusion physics. Our results validate the magnetic confinement design, bringing us closer to a clean, grid-scale fusion energy source.'

Breaking

Related Stories

Scientists May Have Discovered How Alzheimer's Disease Spreads Through the Brain
Science

Scientists May Have Discovered How Alzheimer's Disease Spreads Through the Brain

Scientists have discovered a new mechanism that may explain how Alzheimer's disease spreads through the brain. A protein called Arc, which normally helps brain cells communicate, appears to transport toxic Tau proteins from damaged neurons to healthy ones using tiny extracellular vesicles. The findings, based primarily on mouse studies, suggest that future treatments could slow Alzheimer's progression by blocking this transfer rather than removing Tau entirely. While the research is promising, experts caution that human studies are still needed before therapies can be developed.

Jun 30, 20267 min read